The Self-Driving Lab
AI-driven robotics for challenging biologics formulation. We replace slow, manual formulation workflows with a closed-loop platform that cuts development timelines and material usage; bringing antibody therapies home, faster.
Learn More:
Matthew Tamasi, PhD | Co-Founder & CEO
matthew.tamasi@plexymer.com
New Site Under Construction